Details

Autor(en) / Beteiligte

• Tsai, Jessica
• Cejas, Paloma
• Coppola, Marissa
• Wang, Dayle
• Patel, Smruti
• Wu, David
• Arounleut, Phonepasong
• Wei, Xin
• Zhou, Ningxuan
• Syamala, Sudeepa
• Dubois, Frank
• Pelton, Kristine
• Vogelzang, Jayne
• Sousa, Cecilia
• Baguette, Audrey
• Chen, Xiaolong
• Condurat, Alexandra
• Dixon-Clarke, Sarah
• Zhou, Kevin
• Lu, Sophie
• Gonzalez, Elizabeth
• Chacon, Madison
• Digiacomo, Jeromy
• Kumbhani, Rushil
• Novikov, Dana
• Tsoli, Maria
• Ziegler, David
• Dirksen, Uta
• Jager, Natalie
• Balsubramanian, Gnana Prakash
• Kramm, Christof
• Nathrath, Michaela
• Bielack, Stefan
• Baker, Suzanne
• Zhang, Jinghui
• McFarland, James
• Getz, Gad
• Aguet, Francois
• Jabado, Nada
• Witt, Olaf
• Pfister, Stefan
• Ligon, Keith
• Hovestadt, Volker
• Kleinman, Claudia
• Long, Henry
• Jones, David
• Bandopadhayay, Pratiti
• Phoenix, Timothy

Titel

DIPG-20. DELINEATING MEDIATORS OF ONCOGENESIS IN FOXR2-EXPRESSING DIFFUSE MIDLINE GLIOMAS

Ist Teil von

• Neuro-oncology (Charlottesville, Va.), 2023-06, Vol.25 (Supplement_1), p.i17-i17

Ort / Verlag

US: Oxford University Press

Erscheinungsjahr

2023

Link zum Volltext

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Abstract BACKGROUND Diffuse midline gliomas (DMGs) are a universally fatal brain tumor of childhood. While histone mutations are a critical tumor initiating event, they are insufficient to drive gliomagenesis. Histone mutations co-occur with somatic alterations in other pathways including TP53, MAPK, and MYC signaling. However, the mechanisms through which these pathways are activated have not been fully elucidated. METHODS We applied an integrative approach using transcriptomics, epigenetics, proteomics, in vitro cancer models, and in vivo mouse models to systematically evaluate how FOXR2 mediates gliomagenesis. RESULTS We have recently found that a subset of DMGs aberrantly express FOXR2, a forkhead transcription factor. FOXR2 is both sufficient to enhance tumor formation, and necessary for FOXR2-expressing DMGs. While FOXR2 indeed enhances MYC protein stability, FOXR2 exerts oncogenesis through MYC-independent functions and specifically hijacks E26-transformation specific (ETS) transcriptional circuits and FOXR2 DNA-binding is highly enriched at ETS motifs. We have performed proteomic and phospho-proteomic analysis of FOXR2-expressing human neural stem cells to identify proteins and phospho-sites that are highly enriched in FOXR2-expressing cells. CONCLUSION Taken together, this study elucidates how FOXR2 interacts with ETS transcription factors to mediate oncogenesis in FOXR2-expressing diffuse midline gliomas.